Novo Nordisk A/S (NVO)
47.42
-1.03
(-2.13%)
USD |
NYSE |
Feb 20, 16:00
47.45
+0.03
(+0.06%)
Pre-Market: 20:00
Novo Nordisk Market Cap : 210.86B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.81B |
| Evaxion AS | 27.44M |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Viking Therapeutics, Inc. | 3.586B |
| DBV Technologies SA | 1.179B |
Market Cap Related Metrics
| PE Ratio | 13.67 |
| PS Ratio | 4.516 |
| PEG Ratio | 2.421 |
| Price to Book Value | 9.116 |
| Price to Free Cash Flow | 47.96 |
| Price | 47.42 |
| Earnings Yield | 7.31% |
| PEGY Ratio | 1.472 |
| Operating PE Ratio | 10.97 |
| Normalized PE Ratio | 13.67 |